The Blue Cross and Blue Shield plan that Indianapolis-based WellPoint Inc. operates in Connecticut has backed out of managing
part of an insurance program rather than disclose the rates it pays doctors and its approach to denying prescription drug
payments. Did WellPoint make the right call? How deep should government dig into a companyâ??s internal operations?